Nurse Practitioner · Mesa, AZ
NPI
1902477870
Since 2021
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3155 E Southern Ave Ste 203
Mesa, AZ, 85204
Phone (480) 325-8173
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,273
90 services
Medicare patients, 2024
50
Average age 74
Drug cost, 2024
$1.6M
3,259 prescriptions
Company payments, 2025
$2,810
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathryn Voight was code 99214 (office e&m - established), 50 times for 49 patients. In total Kathryn Voight billed 90 services in 7 codes, and Medicare paid $5,273.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 50 | 49 | $82.74 | $4,137 |
Medicare prescription drug claims, 2024
In 2024, the drug Kathryn Voight prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 703 prescriptions and refills. In total Kathryn Voight wrote 3,259 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 703 | 865 | 288 | $21K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 537 | 751 | 145 | $466K |
| Prednisone Generic | 384 | 512 | 217 | $1,494 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 168 | 217 | 57 | $134K |
| Fluconazole Generic | 118 | 227 | 48 | $13K |
| Montelukast Sodium Generic | 112 | 302 | 42 | $1,416 |
| Breo Ellipta Fluticasone/Vilanterol | 98 | 150 | 27 | $58K |
| Azithromycin Generic | 84 | 92 | 64 | $346 |
| Omeprazole Generic | 82 | 161 | 28 | $911 |
| Doxycycline Hyclate Generic | 82 | 84 | 63 | $604 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 81 | 157 | 24 | $21K |
| Symbicort Budesonide/Formoterol Fumarate | 58 | 98 | 24 | $21K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 50 | 50 | 45 | $342 |
| Roflumilast Generic | 47 | 59 | 12 | $2,176 |
| Fluticasone Propionate Generic | 46 | 119 | 27 | $1,304 |
Brand drugs: - claims; generic drugs: 1,698 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathryn Voight $2,810 ($2,810 in general payments such as food, travel and fees) from 24 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $456.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $456 |
| Regeneron Healthcare Solutions, Inc. REGN | 14 | $333 |
| GlaxoSmithKline, LLC. GSK | 19 | $329 |
| Genzyme Corporation SNY | 12 | $205 |
| Verona Pharma, Inc. VRNA | 8 | $196 |
| Axsome Therapeutics, Inc. AXSM | 6 | $167 |
| Grifols USA, LLC | 5 | $131 |
| Novo Nordisk Inc NVO | 1 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $122 |
| Actelion Pharmaceuticals US, Inc. JNJ | 4 | $120 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.